Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by HighteawithIntrepidon Aug 16, 2018 11:51pm

122 Views

Post# 28475969

RE:RE:RE:RE:RE:33Mill loss CAD = 132 MILL CAD annual loss, is this linear

Sorry in the land of CA’s I think you are under
PL’s spell. The lack of cash is our number one
problem end of story. Until we get a deal, FDA
approval or bite the bullet and do a rights offering
we are cannon fodder.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"